| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/09/1996 | US5506132 Monoclonal antibodies or binding fragments thereof |
| 04/09/1996 | US5506127 Therapeutic grade thrombin produced by chromatography |
| 04/09/1996 | US5506126 Diagnosis, therapy antigen |
| 04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
| 04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
| 04/09/1996 | US5506097 Contacting alzheimer amyloid beta-protein with ebelactone a or para-amidinophenylmethanesulfonyl fluoride |
| 04/09/1996 | US5505967 Pharmaceutical loaded into alkali insoluble particle in enteric material; for delivery to peyer's glands |
| 04/09/1996 | US5505955 Anti-diarrheic product and method of treating rotavirus-associated infection |
| 04/09/1996 | US5505945 Method and compositions for the direct concentrated delivery of passive immunity |
| 04/09/1996 | US5505943 Compositions containing protease produced by vibrio and method of use in debridement and wound healing |
| 04/09/1996 | US5505942 Administering a protease |
| 04/09/1996 | US5505931 Isothiocyanate containing anhydride compounds; useful for controlled release of nucleophilic group of diagnostic or therapeutic agent |
| 04/07/1996 | CA2159957A1 Regulated genes by stimulation of chondrocytes with il-1.beta. |
| 04/05/1996 | CA2159700A1 Method for the separation of recombinant pro-factor ix from recombinant factor ix |
| 04/04/1996 | WO1996020276A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | WO1996010176A1 Means for reversibly inactivating biological molecules |
| 04/04/1996 | WO1996010092A1 Novel mammalian protein associated with uncontrolled cell division |
| 04/04/1996 | WO1996010088A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 04/04/1996 | WO1996010087A1 Method for treatment of cancers by regulating the activity of ras proteins |
| 04/04/1996 | WO1996010080A1 Finderons and methods of their preparation and use |
| 04/04/1996 | WO1996010041A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 04/04/1996 | WO1996010040A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 04/04/1996 | WO1996010039A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | WO1996010037A1 Peptide inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010036A1 A process for the quantitative synthesis of 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic acid and derivatives thereof |
| 04/04/1996 | WO1996010035A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010034A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010014A1 Aldehyde derivatives as upsteine protease inhibitors |
| 04/04/1996 | WO1996010011A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009838A1 METHOD OF TREATING MACULAR DEGENERATION USING TGF-$g(b) |
| 04/04/1996 | WO1996009837A1 Muramyl peptide compositions for inhibiting hiv replication |
| 04/04/1996 | WO1996009836A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009831A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 04/04/1996 | WO1996009830A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 04/04/1996 | WO1996009823A1 Hypoglycemic agent from cryptolepis |
| 04/04/1996 | WO1996009821A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009814A1 Spray-dried microparticles as therapeutic vehicles |
| 04/04/1996 | WO1996009813A1 Diketopiperazine-based delivery systems |
| 04/04/1996 | WO1996008274A3 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents |
| 04/04/1996 | WO1996004933A3 Cck antibodies used to improve feed efficiency |
| 04/04/1996 | WO1996004306A3 Muteins of mammalian cytokines |
| 04/04/1996 | WO1996003106A3 Allergenic peptides derived from poa pratensis |
| 04/04/1996 | WO1996000288A3 Class bi and ci scavenger receptors |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | DE4445562C1 Klonierung, Expression und Charakterisierung einer neuen Form der Phosphatidylinositol-3-Kinase Cloning, expression and characterization of a new form of phosphatidylinositol 3-kinase |
| 04/04/1996 | DE4434551A1 Peptide aus der Sequenz des hPTH (1-37) Peptides from the sequence of hPTH (1-37) |
| 04/04/1996 | DE4433572A1 New metal complexes of cyclic peptide(s), esp. with aspartic acid units |
| 04/04/1996 | DE4433564A1 New metal complexes of linear peptide(s) |
| 04/04/1996 | CA2208599A1 Tissue specific hypoxia regulated therapeutic constructs |
| 04/04/1996 | CA2201395A1 Composition and method for allogeneic mononuclear cell immunotherapy |
| 04/04/1996 | CA2201351A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201350A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201349A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201346A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2201122A1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 04/04/1996 | CA2200993A1 Compositions of muramyl peptides inhibiting the replication of hiv |
| 04/04/1996 | CA2200845A1 Finderons and methods of their preparation and use |
| 04/04/1996 | CA2200338A1 Polypeptides and their use in treatment and prophylaxis of auto-immune disease |
| 04/04/1996 | CA2199954A1 Spray-dried microparticles as therapeutic vehicles |
| 04/04/1996 | CA2197904A1 Deffective recombinant adenoviruses with inactivated iva2 gene |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | CA2196182A1 Aldehyde derivatives as upsteine protease inhibitors |
| 04/03/1996 | EP0704532A2 Recombinant chimeric proteins and methods of use thereof |
| 04/03/1996 | EP0704527A2 DNA sequences encoding biosynthetic insulin precursors and process for prepation of insulin |
| 04/03/1996 | EP0704526A1 hTFIIIA gene |
| 04/03/1996 | EP0704457A1 Allergenic proteins of natural rubber latex, their production and use in assays |
| 04/03/1996 | EP0704221A2 A conjugate useful in gene transfer and a method of producing the same |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704219A2 A novel osteoblastic proliferative factor |
| 04/03/1996 | EP0704218A2 Bone reinforcing agent and foods and drinks product containing the same |
| 04/03/1996 | EP0704056A1 Leukocyte adhesion assay |
| 04/03/1996 | EP0703988A1 Mesothelial cell gene therapy |
| 04/03/1996 | EP0703985A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
| 04/03/1996 | EP0703980A1 Intracellular binding proteins and use thereof |
| 04/03/1996 | EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 04/03/1996 | EP0703925A1 Production of antibody fragments |
| 04/03/1996 | EP0703924A1 Biologically active vasopressin analogues |
| 04/03/1996 | EP0703923A1 Factor vii-derived peptides |
| 04/03/1996 | EP0703922A1 Immunoglobulin g concentrate for therapeutical use and method for producing same |
| 04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
| 04/03/1996 | EP0703900A1 PROCESS FOR THE PREPARATION OF PHENYLALANINE DERIVATIVES OR HOMOLOGUES CONTAINING A GUANIDINO OR MODIFIED GUANIDINO GROUP USEFUL FOR THE PREPARATION GnRH OF ANTAGONISTIC PEPTIDES |
| 04/03/1996 | EP0703788A1 A stabilised phenylalanine ammonia lyase |
| 04/03/1996 | EP0703787A1 Cell growth regulators |
| 04/03/1996 | EP0703786A1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0703784A1 Release and mobilisation of haematopoietic cells |
| 04/03/1996 | EP0703783A1 Hla-a2.1 binding peptides and their uses |
| 04/03/1996 | EP0703779A1 Compressible enzyme powder |
| 04/03/1996 | EP0703776A1 Utilization of a peptide having a lysin group and an alanine group in the terminal position for the preparation of a depigmenting composition, and depigmenting composition thus obtained |
| 04/03/1996 | EP0535091B1 Osteoinductive pharmaceutical formulations |
| 04/03/1996 | EP0494247B1 Reducing non-target retention of immunoconjugates and metabolites thereof |
| 04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1996 | CN1119829A Vaccine compositions containing 3-O deacylated monophosphoryl lipid a |
| 04/03/1996 | CN1119677A Molecular guide medicine gene clone containing IL_II and toxin gene fragment and expressing |
| 04/03/1996 | CN1119650A Motilin-like polypeptides with gastrointestinal motor stimulating activity |
| 04/03/1996 | CN1119649A Glycopeptide antibiotic derivatives |
| 04/03/1996 | CN1031465C DNA clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 04/02/1996 | US5504197 DNA encoding neurotrophic growth factors |
| 04/02/1996 | US5504194 Lymphocyte adhesion receptor for high endothelium, CD44 |